These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38488817)

  • 21. The clinical and economic benefits associated with novel multi-cancer early detection tests: conference highlights from the 2022 ISPOR Annual Meeting.
    Nabavizadeh N
    Am J Manag Care; 2022 Aug; 28(7 Suppl):S123-S132. PubMed ID: 36067342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in screening and prevention of women's cancers - Volume 65 multiple choice answers.
    Best Pract Res Clin Obstet Gynaecol; 2020 Jul; 66():119-128. PubMed ID: 32819619
    [No Abstract]   [Full Text] [Related]  

  • 23. Performance on preventive cancer screening tests in the ambulatory setting by internal medicine resident physicians.
    An PG; Ashburner JM; Fosburgh BW; Atlas SJ
    Teach Learn Med; 2010 Jan; 22(1):45-9. PubMed ID: 20391283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives.
    Loomans-Kropp HA; Umar A; Minasian LM; Pinsky PF
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):512-514. PubMed ID: 35253043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal Immunochemical Test Screening for Colon and Rectal Cancer.
    Ann Intern Med; 2018 Nov; 169(9):. PubMed ID: 30285048
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer DNA blood test gets real-world trial.
    Kaiser J
    Science; 2020 May; 368(6490):461. PubMed ID: 32355013
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
    Andriole GL; Kibel AS
    Cancer; 2011 Mar; 117(6):1110-2. PubMed ID: 20960524
    [No Abstract]   [Full Text] [Related]  

  • 28. Population-based screening for cancer: hope and hype.
    Shieh Y; Eklund M; Sawaya GF; Black WC; Kramer BS; Esserman LJ
    Nat Rev Clin Oncol; 2016 Sep; 13(9):550-65. PubMed ID: 27071351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis.
    Yang L; Wang S; Zhang L; Sheng C; Song F; Wang P; Huang Y
    BMC Cancer; 2020 Jun; 20(1):499. PubMed ID: 32487106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breath analysis for colorectal cancer screening.
    Altomare DF
    Colorectal Dis; 2016 Dec; 18(12):1127-1128. PubMed ID: 27507419
    [No Abstract]   [Full Text] [Related]  

  • 31. Updated USPSTF screening guidelines may reduce lung cancer deaths.
    Marshall RC; Tiglao SM; Thiel D
    J Fam Pract; 2021 Sep; 70(7):347-349. PubMed ID: 34818167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and localization of surgically resectable cancers with a multi-analyte blood test.
    Cohen JD; Li L; Wang Y; Thoburn C; Afsari B; Danilova L; Douville C; Javed AA; Wong F; Mattox A; Hruban RH; Wolfgang CL; Goggins MG; Dal Molin M; Wang TL; Roden R; Klein AP; Ptak J; Dobbyn L; Schaefer J; Silliman N; Popoli M; Vogelstein JT; Browne JD; Schoen RE; Brand RE; Tie J; Gibbs P; Wong HL; Mansfield AS; Jen J; Hanash SM; Falconi M; Allen PJ; Zhou S; Bettegowda C; Diaz LA; Tomasetti C; Kinzler KW; Vogelstein B; Lennon AM; Papadopoulos N
    Science; 2018 Feb; 359(6378):926-930. PubMed ID: 29348365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study.
    Falanga A; Santoro A; Labianca R; De Braud F; Gasparini G; D'Alessio A; Barni S; Iacoviello L;
    Thromb Res; 2016 Apr; 140 Suppl 1():S55-9. PubMed ID: 27067979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of colorectal cancer screening.
    Steele RJC
    Colorectal Dis; 2019 Mar; 21 Suppl 1():14-15. PubMed ID: 30809910
    [No Abstract]   [Full Text] [Related]  

  • 35. [Breast cancer screening: involving women in medical controversy?].
    Nau JY
    Rev Med Suisse; 2015 Oct; 11(492):2040-1. PubMed ID: 26672187
    [No Abstract]   [Full Text] [Related]  

  • 36. New Blood Test SEEKs To Detect and Localize Cancer before It's Too Late.
    Bogyo M; Yim JJ; Rosenthal EL
    Biochemistry; 2018 Mar; 57(10):1561-1562. PubMed ID: 29489339
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection.
    Pantel K
    PLoS Med; 2016 Dec; 13(12):e1002205. PubMed ID: 28027295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types.
    Ren S; Zhang Z; Xu C; Guo L; Lu R; Sun Y; Guo J; Qin R; Qin W; Gu J
    Cell Res; 2016 Aug; 26(8):963-6. PubMed ID: 27364686
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early detection or screening in the prevention of prostate cancer?].
    Brenes Bermúdez FJ; Alcántara Montero A
    Semergen; 2017 Mar; 43(2):100-108. PubMed ID: 26960257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with 'interval' colorectal cancers have worse outcomes compared with cancers in patients who decline the National Bowel Cancer Screening Programme - Results from a Multicentre Study.
    George AT; Field A
    Colorectal Dis; 2017 Jun; 19(6):590-591. PubMed ID: 28494513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.